L-Arginine
USP/1042500 - United States Pharmacopeia (USP) Reference Standard
Synonym: (S)
CAS Number: 74-79-3
Empirical Formula (Hill Notation): C6H14N4O2
Molecular Weight: 174.20
MDL Number: MFCD00002635
Linear Formula: H2NC(=NH)NH(CH2)3CH(NH2)CO2H
Product Type: Chemical
API family | arginine |
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C6H14N4O2/c7-4(5(11)12 |
InChI key | ODKSFYDXXFIFQN-BYPYZUCNSA |
manufacturer/tradename | USP |
mp | 222 °C (dec.) (lit.) |
SMILES string | N[C@@H](CCCNC(N)=N)C(O)=O |
Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
Application: | This USP reference standard is intended for use in specified quality tests and assays. Also used to prepare standard and system suitability solutions for identification, assay, and strength analysis using thin-layer chromatography and LC-UV according to the following United States Pharmacopeia (USP) monographs:• Arginine • Arginine Tablets • Arginine Capsules • Aztreonam for Injection • Ceftazidime for Injection • Aztreonam Injection |
Biochem/physiol Actions: | Substrate of nitric oxide synthase, which is converted to citrulline and nitric oxide (NO). Induces insulin release by a nitric oxide-dependent mechanism. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets, has been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 1 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
mp | 222 °C (dec.) (lit.) |
UNSPSC | 41116107 |